Introduction
Telemedicine went from a niche service to a central part of health care in just a few years. During the COVID-19 pandemic, governments and insurers rapidly relaxed long-standing rules on video visits, telephone care, and remote prescribing. Suddenly, millions of patients could see a clinician without traveling, arranging childcare, taking unpaid time off work, or sitting in a waiting room.
Now the emergency phase is over, but telemedicine is not. A major new 2026 position paper from the American College of Physicians (ACP), “Telemedicine Policy and Practice,” argues that virtual care should remain part of mainstream medicine—if it is used thoughtfully and supported by smart policy. That is a big “if.” The same tools that make care easier can also create new problems: fragmented care, missed diagnoses, unequal access for people without broadband or private space, and confusion over payment, licensure, and prescribing.
The central question is no longer whether telemedicine works. It clearly can. The harder question is when it works best, for whom, and under what rules.
What the New ACP Paper Adds
The ACP paper updates earlier guidance in light of the pandemic-era expansion of telemedicine and the policy turbulence that followed. Its message is practical rather than ideological. Telemedicine, the authors emphasize, is most valuable when integrated into an ongoing clinical relationship rather than treated as a stand-alone convenience product disconnected from a patient’s usual care.
That distinction matters. A virtual follow-up with your own primary care doctor after a medication change is very different from an anonymous one-time online visit for chest pain, severe abdominal pain, or a new neurologic deficit. In one case, telemedicine can strengthen continuity. In the other, it may delay necessary in-person evaluation.
The ACP paper focuses on six big policy areas: access, payment, licensure, prescribing, equity, and patient safety. It also highlights environmental benefits that are often overlooked, including reduced travel, lower fuel use, fewer transportation costs, and lower greenhouse gas emissions.
In other words, telemedicine is no longer just a technology story. It is a care design story, a regulatory story, and increasingly an equity story.
Why Patients Like Virtual Care
The appeal of telemedicine is easy to understand. For many routine needs, it removes friction from health care.
Consider a fictional patient, Michael, a 58-year-old warehouse supervisor with type 2 diabetes and high blood pressure. He works hourly shifts, helps care for his mother, and lives 45 minutes from his clinic. Before telemedicine, every follow-up meant lost wages, a long drive, and a struggle to coordinate schedules. With a virtual visit, Michael can review home blood pressure readings, discuss lab results, adjust medications, and ask questions from his kitchen table.
For patients like Michael, virtual care is not merely convenient. It can make the difference between receiving care and postponing it.
Telemedicine may be especially useful for:
Patients in rural or medically underserved areas
People with mobility limitations or chronic illness
Parents of young children
Workers with inflexible schedules
Patients needing behavioral health follow-up
People who need frequent monitoring for stable chronic conditions
For some specialties, the fit is especially strong. Mental health care, medication management, chronic disease follow-up, dermatology image review, smoking cessation counseling, sleep medicine, and post-hospital check-ins often translate well to virtual formats.
What the Evidence Shows
The scientific literature from the pandemic and post-pandemic years suggests that telemedicine can maintain high patient satisfaction and comparable outcomes for selected conditions, especially when used for follow-up, triage, counseling, and chronic disease management. But the benefits are highly dependent on context.
Randomized and observational studies have supported telehealth for hypertension monitoring, diabetes coaching, mental health treatment, heart failure surveillance, and post-discharge care in some settings. Reviews published over the past several years also suggest that telemedicine can reduce missed appointments and lower patient burden. At the same time, researchers have found that quality can suffer when virtual care substitutes for needed physical examination, diagnostic testing, or continuity with a known care team.
A useful way to think about telemedicine is as a spectrum rather than a single service:
| Telemedicine use | Often a good fit | Use caution | Usually needs in-person care |
|---|---|---|---|
| Video visits | Medication follow-up, counseling, chronic disease review, mild symptom triage | New complex symptoms, poor image/audio quality, language barriers without support | Emergencies, severe pain, suspected stroke, acute abdomen, significant shortness of breath |
| Audio-only visits | Access for patients without video, brief follow-up, behavioral health check-ins | Symptoms requiring visual assessment, medication side effects with physical signs | Conditions needing examination or testing |
| Asynchronous care | Dermatology images, portal advice, refill requests, routine questionnaires | Rapidly changing symptoms, incomplete patient history | Any urgent or unstable condition |
The ACP’s position aligns with this evidence: preserve telemedicine, but do not pretend all visits are interchangeable.
The Policy Knots: Payment, Licensure, and Prescribing
One reason telemedicine expanded so rapidly during COVID-19 was that regulators temporarily removed barriers. Medicare broadened coverage. State licensure rules were loosened. The U.S. Drug Enforcement Administration provided flexibility around prescribing controlled substances in some circumstances. Private insurers followed, though not always consistently.
As emergency waivers expired or changed, the system became uneven. Some telemedicine services remained covered; others faced uncertainty. Clinicians practicing across state lines encountered a patchwork of rules. Prescribing regulations became especially contentious, balancing access against concerns over inappropriate treatment or online pill mills.
The ACP paper calls for policies that support appropriate telemedicine while protecting patients. That means payment structures should not push clinicians to choose virtual visits solely because they are easier to schedule or more profitable. It also means licensure systems should be modernized enough to allow interstate practice when clinically appropriate, while still preserving professional accountability.
Prescribing deserves special attention. Virtual prescribing can be extremely helpful for patients who need continuity of treatment, particularly in primary care and psychiatry. But when online encounters are too superficial, important diagnoses can be missed, misuse risks may go undetected, and patient safety can suffer. The right policy question is not whether remote prescribing is inherently good or bad. It is what safeguards are needed, for which medications, and in what clinical circumstances.
The Equity Problem: Access Is Not the Same as Fairness
At first glance, telemedicine appears to be a great equalizer. In reality, it can either narrow disparities or deepen them.
A patient who lacks home internet, a smartphone, digital literacy, language support, hearing accommodation, or a private room for a visit may not benefit from virtual care at all. Older adults, low-income households, rural communities with weak broadband, people experiencing homelessness, and some patients with disabilities can be left behind if health systems assume everyone can connect seamlessly.
This is why audio-only care remains so important. Critics sometimes dismiss telephone visits as inferior, but for many patients they are the only realistic doorway into care. The ACP argues that policymakers should recognize this reality rather than building telemedicine around an idealized high-speed-video model that excludes vulnerable groups.
Equity also includes cultural and communication needs. A video platform without interpreter integration is not truly accessible. A patient portal written at a college reading level is not truly patient-centered. A clinician who conducts a virtual visit while rushing through poor audio quality is not delivering equal care.
Done well, telemedicine can reduce inequities. Done poorly, it simply relocates them onto a screen.
Safety: What Can Be Missed on a Screen?
The biggest criticism of telemedicine is also the most obvious: a clinician cannot do a full physical examination through a laptop. Even when video quality is excellent, medicine depends on more than conversation. Palpation, auscultation, gait assessment, neurologic examination, skin texture, edema, and subtle signs of distress may be limited or missed.
This does not make telemedicine unsafe by definition. It means the threshold for conversion to in-person care must be clear. High-quality virtual care requires active clinical judgment: What can I safely assess here? What remains uncertain? What symptoms are red flags? Does this patient understand when to seek urgent help?
In Michael’s case, a virtual diabetes follow-up is reasonable. But if he reports crushing chest pain, sudden leg weakness, or severe abdominal pain, the visit should turn immediately into emergency referral—not a prolonged online discussion.
Health systems can improve safety by creating protocols for triage, escalation, documentation, and follow-up. Patients should also be told up front what telemedicine can and cannot do.
Common Misconceptions
Several myths continue to shape public and policy debates.
Myth 1: Telemedicine is always lower-quality care.
Reality: For many routine and follow-up needs, it can be highly effective. Quality depends on the clinical scenario, technology, continuity, and follow-up.
Myth 2: Video is always better than audio.
Reality: Video adds important visual information, but audio-only care may be better than no care at all, especially for patients facing digital barriers.
Myth 3: Telemedicine saves money automatically.
Reality: It can reduce travel costs and time burden for patients, but its effect on overall health spending depends on how it is used. It can improve efficiency, but it can also add extra encounters if poorly integrated.
Myth 4: Virtual care is just a pandemic relic.
Reality: Utilization patterns have changed, but telemedicine is now a normal part of care delivery in many specialties.
Myth 5: Convenience companies and continuity clinics offer the same thing.
Reality: They may look similar on a phone screen, but continuity with a known clinician often leads to better coordination, safer prescribing, and more personalized care.
What Good Telemedicine Looks Like
A strong telemedicine program is not simply a video platform. It has clinical standards.
Good virtual care typically includes:
Clear patient selection for telemedicine versus in-person visits
Reliable technology with privacy safeguards
Easy interpreter access and disability accommodations
Integration with the patient’s medical record
Defined escalation pathways for urgent symptoms
Attention to home data, such as blood pressure, glucose, pulse oximetry, or weight when relevant
Transparent communication about limitations and follow-up plans
Clinicians should ask practical questions early in the visit: Where are you located right now? Are you in a private place? Can you hear and see clearly? If this becomes urgent, what is the fastest way to get you hands-on care?
These are not minor details. They are part of safe medical practice.
Environmental and Everyday Benefits
One underappreciated point in the ACP paper is environmental impact. Fewer car trips to clinics and hospitals can reduce fuel use and greenhouse gas emissions. That may sound secondary to direct patient care, but it reflects something important: health systems shape health beyond the exam room.
Telemedicine also reduces logistical stress. It saves travel time, parking fees, transit costs, and in some cases caregiver burden. For patients with chronic illness, those repeated small savings can add up to substantial improvements in quality of life.
Still, convenience should not become the only metric. The best care is not always the fastest care. The best system preserves convenience where it helps and insists on in-person evaluation where it matters.
What Patients and Clinicians Should Do Now
For patients, the most practical advice is simple: use telemedicine strategically. It is often a good option for medication follow-up, discussing test results, mental health visits, routine chronic disease check-ins, and minor symptom triage. It is a poor substitute for emergency care or for new serious symptoms that may require examination or testing.
For clinicians and health systems, the lesson is to design telemedicine around continuity, not just convenience. Virtual care works best when it complements an existing care relationship and when patients can move easily between remote and in-person services.
For policymakers, the ACP’s position paper offers a middle path. Do not roll back telemedicine to its pre-pandemic limitations. But do not assume every barrier removed during the emergency should disappear permanently either. Payment, licensure, and prescribing policies should reward appropriate use, protect patient safety, and preserve access for those most likely to benefit.
Conclusion
Telemedicine has entered its adult phase. The early excitement was understandable, and so was the backlash. But the real future of virtual care lies between hype and skepticism.
The new ACP guidance makes the case that telemedicine should remain a durable part of health care—especially for follow-up, chronic disease management, behavioral health, and patients who face real barriers to in-person visits. Yet it also reminds us that medicine is not just information exchange. It is observation, judgment, trust, and continuity. Screens can extend those qualities, but they cannot replace them entirely.
The challenge now is not whether to keep telemedicine. It is whether we will build a version that is equitable, safe, connected, and clinically honest about what virtual care can—and cannot—do.
中文摘要
远程医疗已经从疫情期间的应急措施，转变为现代医疗体系中的常规工具。美国内科医师学会2026年最新立场文件指出，远程医疗在慢病管理、随访、心理健康和医疗可及性方面具有明显优势，但前提是支付政策、跨州执业、处方监管、公平性与患者安全得到妥善设计。真正重要的问题不是“远程医疗是否有用”，而是“在什么情境下、对哪些患者、以何种规则使用最合适”。
日本語要約
遠隔医療は、パンデミック時の一時的な代替手段から、医療提供の恒常的な一部へと移行しました。2026年の米国内科学会のポジションペーパーは、遠隔医療が慢性疾患管理、フォローアップ、メンタルヘルス、医療アクセス改善に有用である一方、支払い制度、州をまたぐ診療免許、処方規制、公平性、患者安全を慎重に設計する必要があると示しています。重要なのは、遠隔医療を残すかどうかではなく、どのように安全かつ公平に組み込むかです。
Tóm tắt tiếng Việt
Y tế từ xa không còn chỉ là giải pháp tình thế sau đại dịch mà đã trở thành một phần lâu dài của chăm sóc sức khỏe hiện đại. Bài quan điểm năm 2026 của American College of Physicians cho thấy khám từ xa có thể cải thiện khả năng tiếp cận, hỗ trợ quản lý bệnh mạn tính và chăm sóc sức khỏe tâm thần, nhưng chỉ khi chính sách chi trả, cấp phép hành nghề, kê đơn, công bằng y tế và an toàn người bệnh được thiết kế hợp lý. Câu hỏi cốt lõi không phải là có nên giữ telemedicine hay không, mà là sử dụng nó đúng lúc, đúng người và đúng cách.
References
1. Johnson D, Quinn S, Algase LF, Watkins C, Medical Practice and Quality Committee of the American College of Physicians. Telemedicine Policy and Practice: A Position Paper From the American College of Physicians. Ann Intern Med. 2026 May 12. PMID: 42114091.
2. Mehrotra A, Bhatia RS, Snoswell CL. Paying for Telemedicine After the Pandemic. JAMA. 2021;325(5):431-432.
3. Koonin LM, Hoots B, Tsang CA, et al. Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1595-1599.
4. Eberly LA, Kallan MJ, Julien HM, et al. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(12):e2031640.
5. Contreras CM, Metzger GA, Beane JD, Dedhia PH, Ejaz A, Pawlik TM. Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond. J Gastrointest Surg. 2020;24(7):1692-1697.
6. Centers for Medicare & Medicaid Services. Telehealth. CMS.gov. Accessed 2026.
7. U.S. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances: policy updates and proposed rules. DEA Diversion Control Division. Accessed 2026.
8. World Health Organization. WHO guideline: recommendations on digital interventions for health system strengthening. Geneva: World Health Organization; 2019.
